Table 2 Fat-induced and non-fat-induced MYC signature score in relation to risk of prostate cancer death among men diagnosed with non-metastatic prostate cancer
MYC score | n | Leading edge genes (fat-induced)a | n | Non-leading edge genes (non-fat-induced)b | ||||
|---|---|---|---|---|---|---|---|---|
OR (95% CI)c | OR (95% CI)d | OR (95% CI)e | OR (95% CI)c | OR (95% CI)d | OR (95% CI)e | |||
Animal fat | ||||||||
Tertile 1 (low) | 13 | 1.00 | 1.00 | 1.00 | 17 | 1.00 | 1.00 | 1.00 |
Tertile 2 | 18 | 1.58 (0.73, 3.53) | 1.31 (0.57, 3.08) | 1.27 (0.55, 2.99) | 19 | 1.17 (0.57, 2.44) | 1.03 (0.47, 2.30) | 0.96 (0.43, 2.16) |
Tertile 3 (high) | 31 | 3.44 (1.69, 7.38) | 2.50 (1.14, 5.70) | 2.37 (1.07, 5.43) | 26 | 1.79 (0.90, 3.64) | 1.07 (0.81, 3.70) | 1.66 (0.78, 3.61) |
P, linear trendf | 0.001 | 0.019 | 0.03 | 0.09 | 0.15 | 0.17 | ||
Saturated fat | ||||||||
Tertile 1 (low) | 13 | 1.00 | 1.00 | 1.00 | 16 | 1.00 | 1.00 | 1.00 |
Tertile 2 | 15 | 1.23 (0.55, 2.80) | 1.07 (0.45, 2.59) | 1.05 (0.44, 2.54) | 18 | 1.24 (0.59, 2.64) | 1.17 (0.52, 2.65) | 1.09 (0.48, 2.48) |
Tertile 3 (high) | 34 | 4.02 (1.98, 8.63) | 3.21 (1.47, 7.35) | 3.04 (1.38, 7.01) | 28 | 2.34 (1.18, 4.82) | 1.93 (0.90, 4.23) | 1.86 (0.87, 4.08) |
P, linear trendf | 0.0001 | 0.002 | 0.004 | 0.015 | 0.085 | 0.107 | ||